TERT-N-HSK cell line
Invented by Prof Aloysius Klingelhutz from The University Of Iowa
Invented at The University Of Iowa
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 154448 |
| Antigen/Gene or Protein Targets | Used as an immortal adult human skin keratinocyte line for pathogenesis and inflammation studies |
| Host | Human |
| Tissue | Skin |
| Disease Keywords | Pathogenesis and Inflammation Studies |
| Model | Immortalised Line |
| Relevance | Exhibits normal cellular responses |
| Production Details | Immortalized with TERT |
| Conditional | No |
| Research Area | Microbiology |
| Growth/Phenotype Keywords | normal-human skin keratinocytes |
| Notes | useful for researchers studying diseases of the skin as they pertain to pathogenesis and inflammation |
References: 2 entries
Gourronc et al. 2010. Exp Dermatol. 19(3):279-88. PMID: 19558498.
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA compon
Europe PMC ID: 19558498
Add a reference
References: 2 entries
Gourronc et al. 2010. Exp Dermatol. 19(3):279-88. PMID: 19558498.
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA compon
Add a reference
